These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 32986766)

  • 1. A comparative study of single nucleotide variant detection performance using three massively parallel sequencing methods.
    Trudsø LC; Andersen JD; Jacobsen SB; Christiansen SL; Congost-Teixidor C; Kampmann ML; Morling N
    PLoS One; 2020; 15(9):e0239850. PubMed ID: 32986766
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Whole-genome sequencing is more powerful than whole-exome sequencing for detecting exome variants.
    Belkadi A; Bolze A; Itan Y; Cobat A; Vincent QB; Antipenko A; Shang L; Boisson B; Casanova JL; Abel L
    Proc Natl Acad Sci U S A; 2015 Apr; 112(17):5473-8. PubMed ID: 25827230
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Archived neonatal dried blood spot samples can be used for accurate whole genome and exome-targeted next-generation sequencing.
    Hollegaard MV; Grauholm J; Nielsen R; Grove J; Mandrup S; Hougaard DM
    Mol Genet Metab; 2013; 110(1-2):65-72. PubMed ID: 23830478
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Massively Parallel Sequencing for Rare Genetic Disorders: Potential and Pitfalls.
    McInerney-Leo AM; Duncan EL
    Front Endocrinol (Lausanne); 2020; 11():628946. PubMed ID: 33679611
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A new massively parallel nanoball sequencing platform for whole exome research.
    Xu Y; Lin Z; Tang C; Tang Y; Cai Y; Zhong H; Wang X; Zhang W; Xu C; Wang J; Wang J; Yang H; Yang L; Gao Q
    BMC Bioinformatics; 2019 Mar; 20(1):153. PubMed ID: 30909888
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Investigation of rare and low-frequency variants using high-throughput sequencing with pooled DNA samples.
    Wang J; Skoog T; Einarsdottir E; Kaartokallio T; Laivuori H; Grauers A; Gerdhem P; Hytönen M; Lohi H; Kere J; Jiao H
    Sci Rep; 2016 Sep; 6():33256. PubMed ID: 27633116
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inconsistency and features of single nucleotide variants detected in whole exome sequencing versus transcriptome sequencing: A case study in lung cancer.
    O'Brien TD; Jia P; Xia J; Saxena U; Jin H; Vuong H; Kim P; Wang Q; Aryee MJ; Mino-Kenudson M; Engelman JA; Le LP; Iafrate AJ; Heist RS; Pao W; Zhao Z
    Methods; 2015 Jul; 83():118-27. PubMed ID: 25913717
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of Exome and Genome Sequencing Technologies for the Complete Capture of Protein-Coding Regions.
    Lelieveld SH; Spielmann M; Mundlos S; Veltman JA; Gilissen C
    Hum Mutat; 2015 Aug; 36(8):815-22. PubMed ID: 25973577
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A practical method to detect SNVs and indels from whole genome and exome sequencing data.
    Shigemizu D; Fujimoto A; Akiyama S; Abe T; Nakano K; Boroevich KA; Yamamoto Y; Furuta M; Kubo M; Nakagawa H; Tsunoda T
    Sci Rep; 2013; 3():2161. PubMed ID: 23831772
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exome sequencing covers >98% of mutations identified on targeted next generation sequencing panels.
    LaDuca H; Farwell KD; Vuong H; Lu HM; Mu W; Shahmirzadi L; Tang S; Chen J; Bhide S; Chao EC
    PLoS One; 2017; 12(2):e0170843. PubMed ID: 28152038
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Whole-genome sequencing offers additional but limited clinical utility compared with reanalysis of whole-exome sequencing.
    Alfares A; Aloraini T; Subaie LA; Alissa A; Qudsi AA; Alahmad A; Mutairi FA; Alswaid A; Alothaim A; Eyaid W; Albalwi M; Alturki S; Alfadhel M
    Genet Med; 2018 Nov; 20(11):1328-1333. PubMed ID: 29565419
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analytical validation of whole exome and whole genome sequencing for clinical applications.
    Linderman MD; Brandt T; Edelmann L; Jabado O; Kasai Y; Kornreich R; Mahajan M; Shah H; Kasarskis A; Schadt EE
    BMC Med Genomics; 2014 Apr; 7():20. PubMed ID: 24758382
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Validated WGS and WES protocols proved saliva-derived gDNA as an equivalent to blood-derived gDNA for clinical and population genomic analyses.
    Kvapilova K; Misenko P; Radvanszky J; Brzon O; Budis J; Gazdarica J; Pos O; Korabecna M; Kasny M; Szemes T; Kvapil P; Paces J; Kozmik Z
    BMC Genomics; 2024 Feb; 25(1):187. PubMed ID: 38365587
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Variant detection sensitivity and biases in whole genome and exome sequencing.
    Meynert AM; Ansari M; FitzPatrick DR; Taylor MS
    BMC Bioinformatics; 2014 Jul; 15(1):247. PubMed ID: 25038816
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Twist exome capture allows for lower average sequence coverage in clinical exome sequencing.
    Yaldiz B; Kucuk E; Hampstead J; Hofste T; Pfundt R; Corominas Galbany J; Rinne T; Yntema HG; Hoischen A; Nelen M; Gilissen C;
    Hum Genomics; 2023 May; 17(1):39. PubMed ID: 37138343
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Added Value of Reanalysis of Whole Exome- and Whole Genome Sequencing Data From Patients Suspected of Primary Immune Deficiency Using an Extended Gene Panel and Structural Variation Calling.
    Mørup SB; Nazaryan-Petersen L; Gabrielaite M; Reekie J; Marquart HV; Hartling HJ; Marvig RL; Katzenstein TL; Masmas TN; Lundgren J; Murray DD; Helleberg M; Borgwardt L
    Front Immunol; 2022; 13():906328. PubMed ID: 35874679
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical sequencing: is WGS the better WES?
    Meienberg J; Bruggmann R; Oexle K; Matyas G
    Hum Genet; 2016 Mar; 135(3):359-62. PubMed ID: 26742503
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recommendations for whole genome sequencing in diagnostics for rare diseases.
    Souche E; Beltran S; Brosens E; Belmont JW; Fossum M; Riess O; Gilissen C; Ardeshirdavani A; Houge G; van Gijn M; Clayton-Smith J; Synofzik M; de Leeuw N; Deans ZC; Dincer Y; Eck SH; van der Crabben S; Balasubramanian M; Graessner H; Sturm M; Firth H; Ferlini A; Nabbout R; De Baere E; Liehr T; Macek M; Matthijs G; Scheffer H; Bauer P; Yntema HG; Weiss MM
    Eur J Hum Genet; 2022 Sep; 30(9):1017-1021. PubMed ID: 35577938
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Systematic dissection of biases in whole-exome and whole-genome sequencing reveals major determinants of coding sequence coverage.
    Barbitoff YA; Polev DE; Glotov AS; Serebryakova EA; Shcherbakova IV; Kiselev AM; Kostareva AA; Glotov OS; Predeus AV
    Sci Rep; 2020 Feb; 10(1):2057. PubMed ID: 32029882
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Use of Non-Variant Sites to Improve the Clinical Assessment of Whole-Genome Sequence Data.
    Ferrarini A; Xumerle L; Griggio F; Garonzi M; Cantaloni C; Centomo C; Vargas SM; Descombes P; Marquis J; Collino S; Franceschi C; Garagnani P; Salisbury BA; Harvey JM; Delledonne M
    PLoS One; 2015; 10(7):e0132180. PubMed ID: 26147798
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.